Dr Franz Humer is currently an Independent Director of Allogene Therapeutics, Chairman of PCI Services Inc, Advisory Board member of LetterOne Holdings, Senior Advisor to Target PharmaSolutions (a data solutions company for the pharmaceutical and biotech industries), and Healthcare Advisor to Temasek Holdings (Singapore) and Advisor to a number of start-up companies.
Professional experience from positions in the pharmaceuticals industry at, among others, Schering Plough Corporation and Roche Holdings Ltd. In March 2014, Franz retired as Chairman of Roche Holding AG, capping a transformative 15-year tenure as Chairman and/or Chief Executive Officer.
Franz was also Chairman of Diageo, the world’s leading spirits company, an Independent Director with Citigroup Inc., Chugai Pharmaceuticals Ltd (Japan), Arix Bioscience plc, Kite Pharma (Biotech company in Los Angeles).
Mentor suggestions
Claudio Costamagna is Executive Chairman of CC & Soci and he sits on the Board of FTI Consulting, a business advisory group listed on the New York Stock Exchange, and three Italian private companies: Italiana Petroli SpA, Finarvedi SpA, holding company of the Arvedi Group and Salini Costruttori SpA, holding company of the Italian industrial group Webuild.
Peter Livanos is Chairman of Gaslog Ltd, Ceres Hellenic Shipping Enterprises Ltd, EnergyLog Ltd, DryLog Ltd and TankLog Ltd. He is a Director of MW&L and holds directorships and memberships in various international companies and committees. He is a member of the Council of the American Bureau of Shipping and chairman of the Greek National Committee. Peter is also a member of the Board of Trustees for New York-Presbyterian Hospital.
Sir Peter Bazalgette is Chairman of ITV plc and the Chairman of Lovecraft Group ltd, a venture-backed e-commerce company. He is also a Non-Executive Director of UK Research and Innovation, and an Advisory Board member of Bartle Bogle Hegarty ltd. Sir Peter is also Honorary Professor of Creative Industries at the University of Manchester.
Pascal Colombani previously chaired the Supervisory Board of Areva, was Chairman of Valeo SA and was Chairman and Chief Executive Officer of the French Atomic Energy Commission. Pascal is President of TII Strategies SASU, a consulting and investment company, since 2014. He also serves as a member of the EMEA advisory board of JPMorgan Chase, as Senior Advisor of Kearney, a global management consulting firm, as a Senior Advisor of Truffle Capital, and as the Lead Director at TechnipFMC plc.